Crescent Capital BDC, Inc.
No SEC Form 4 filings for $CCAP in the last 30 days.
Crescent Capital BDC, Inc. CEO Jason Breaux recently purchased 5,000 shares of company common stock in an open-market transaction on May 20, 2026, at a price of $11.19 per share. This acquisition increased his direct holdings to 52,636 shares, signaling positive sentiment towards the company. The transaction was detailed in a Form 4 SEC filing, which also provides further insights into the purchase.
A director at Crescent Capital BDC, Steven F. Strandberg, recently purchased 85,000 shares of the company's common stock for $958,485. This insider buying occurred while the stock was trading near its 52-week low following a significant decline. The article also provides recent analyst ratings and corporate governance updates for Crescent Capital BDC.
Crescent Capital BDC (CCAP) announced its Q1 2026 results, reporting a net investment income of $0.42 per share but a net loss of $0.42 per share due to investment losses. The company also declared a regular dividend of $0.34 per share for Q2 2026 and special dividends totaling $0.09 per share, payable in three installments. Furthermore, CCAP reduced its base management and incentive fees to better align with shareholder interests.
